Guanidine

Guanidine

SCHEMBL8517609

CC(=Cc1cc(F)c(Oc2cccc(N(C)C)c2)c(F)c1)C(=O)O.Cl.N=C(N)N

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2

The experimentally established mechanism targets of Guanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
F10 P00742 8/20 0.41
F2 P00734 5/20 0.41
F3 P13726 2/20 0.40
F7 P08709 1/20 0.40
SLC9A3 P48764 4/20 0.38
FFAR1 O14842 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
PLG P00747 1/20 0.36
PLAU P00749 1/20 0.36
PLAT P00750 1/20 0.36
AKR1C3 P42330 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8440642 0.94 BCHE (0.41) F10F2F3F7SLC9A3
SCHEMBL8374494 0.94 BCHE (0.41) F10F2F3F7SLC9A3
SCHEMBL8439128 0.82 BCHE (0.41) F10F2FFAR1BCHEACHE
SCHEMBL8374887 0.82 BCHE (0.41) F10F2FFAR1BCHEACHE
SCHEMBL8377548 0.80 MAPT (0.37) F10F2SLC9A3FFAR1BCHE
SCHEMBL2565950 0.79 AKR1C3 (0.53) SLC9A3AKR1C3
SCHEMBL2565952 0.79 AKR1C3 (0.53) SLC9A3AKR1C3
SCHEMBL8439020 0.77 FFAR1 (0.43) F10F2F3F7FFAR1
SCHEMBL8373819 0.77 FFAR1 (0.43) F10F2F3F7FFAR1
SCHEMBL8442998 0.73 FFAR1 (0.39) F10F2F3F7FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883133-A CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-16 US disclosed